Epidemiology of respiratory syncytial virus infection in Washington, D.C. II. Infection and disease with respect to age, immunologic status, race and sex.
about
Respiratory syncytial virus infection alters surfactant protein A expression in human pulmonary epithelial cells by reducing translation efficiencyBiochemical prevention and treatment of viral infections - a new paradigm in medicine for infectious diseasesHyperresponsiveness to inhaled but not intravenous methacholine during acute respiratory syncytial virus infection in miceSurveillance recommendations based on an exploratory analysis of respiratory syncytial virus reports derived from the European Influenza Surveillance System.Duration of shedding of respiratory syncytial virus in a community study of Kenyan childrenRespiratory syncytial virus infection: immune response, immunopathogenesis, and treatmentIntranasal antibody prophylaxis for protection against viral disease.Effects of social and family factors on viral respiratory infection and illness in the first year of lifeComplications of pediatric laryngotracheal reconstruction: prevention strategies.Multiplex assay for detection of strain-specific antibodies against the two variable regions of the G protein of respiratory syncytial virus.Respiratory syncytial virus infection in adultsEpidemiology and clinical presentations of the four human coronaviruses 229E, HKU1, NL63, and OC43 detected over 3 years using a novel multiplex real-time PCR method.Current concepts and progress in RSV vaccine development.Enzyme-linked immunosorbent assay for measurement of serological response to respiratory syncytial virus infection.Altered pathogenesis of severe pneumovirus infection in response to combined antiviral and specific immunomodulatory agentsImmunization strategies for the prevention of pneumovirus infections.Potential therapeutic implications of new insights into respiratory syncytial virus disease.Relationship between clinical severity of respiratory syncytial virus infection and subtypeAssociation of RSV-related hospitalization and non-compliance with palivizumab among commercially insured infants: a retrospective claims analysis.Safety and bioequivalency of three formulations of respiratory syncytial virus-enriched immunoglobulin.Macrophages are required for dendritic cell uptake of respiratory syncytial virus from an infected epithelium.Development of interleukin 6 and tumor necrosis factor alpha activity in nasopharyngeal secretions of infants and children during infection with respiratory syncytial virus.Molecular characterization of an outbreak of respiratory syncytial virus (subgroup A) in Havana, Cuba, by monoclonal antibodies and restriction mapping (N gene).Local variability in respiratory syncytial virus disease severity.Low incidence of respiratory syncytial virus hospitalisations in haemodynamically significant congenital heart disease.Intravenous immunoglobulin treatment of respiratory syncytial virus infections in infants and young children.Resistance to human respiratory syncytial virus (RSV) infection induced by immunization of cotton rats with a recombinant vaccinia virus expressing the RSV G glycoproteinHuman metapneumovirus infection among children hospitalized with acute respiratory illness.Pediatric RSV infection during two winter seasons in British Columbia: A role for subgroup analysis in young children?Pediatric infections.Mucosal inoculation with an attenuated mouse pneumovirus strain protects against virulent challenge in wild type and interferon-gamma receptor deficient mice.Applicability of a real-time quantitative PCR assay for diagnosis of respiratory syncytial virus infection in immunocompromised adults.Respiratory syncytial virus infection and neurologic abnormalities: retrospective cohort study.The pathogenesis of respiratory syncytial virus infection in infant ferretsA comparison of influenza and respiratory syncytial virus infections among infants admitted to hospital with acute respiratory infectionsComparison of enzyme-linked immunosorbent assay and neutralization techniques for measurement of antibody to respiratory syncytial virus: implications for parenteral immunization with live virus vaccineDevelopment of antibody-dependent cell-mediated cytotoxicity in the respiratory tract after natural infection with respiratory syncytial virus.The natural history of respiratory syncytial virus in a birth cohort: the influence of age and previous infection on reinfection and diseaseEffect of respiratory syncytial virus and virus-antibody complexes on the oxidative metabolism of human neutrophilsInability to evoke a long-lasting protective immune response to respiratory syncytial virus infection in mice correlates with ineffective nasal antibody responses
P2860
Q24646598-55F7B266-5D04-4117-B743-C38EABEB5AC9Q24801934-41EDF72E-17DA-4D4D-880C-CCFFC336678CQ25256827-C73E6317-E768-4AD1-978F-AF51AE8AB832Q30821133-31A81971-DBCC-41B2-A4EA-857810EC9957Q33526047-3AE2D7F2-AEBD-43F8-B441-53ACADBA3F7EQ33588916-47D3CB9C-E57F-4C86-ADDB-7A039B0FBAE6Q33683058-1E7490C2-98BE-4795-9A86-159591AF254CQ33685050-55B989F3-64F1-4881-BA44-5AFB3BF98EDAQ33783161-8016E7C5-9AD7-408F-873B-37413F4D8AC3Q33943306-1C4593AC-61DE-41B3-B8A7-6B81EA34DA0DQ33961877-D43FCDD0-4215-4FF4-8E68-131775E9E249Q34046313-8C9E5214-4545-4DD6-A15F-8F715AF902F7Q34396689-C663C0AB-EFCC-4EC7-97C7-1F4856F47C9FQ34447185-E7A0A68F-4AC1-4B9F-843D-446F6BF6B38DQ34465570-D2C5609D-7F31-4591-AC27-9438EF8F23E9Q34615678-A4B14C35-1D35-40FE-B3CF-6E6476D41401Q34740814-A9DEF092-D845-4165-84D7-C6E55B4D10FDQ34799084-F7EC5104-E68C-4423-9668-61B49F287F26Q34839654-285C8F9D-FB37-43A3-B4FF-F3C977B59022Q35112303-E4F814F2-75EE-4627-91BC-1AA73B33531FQ35126075-3A309F50-40FC-403B-BF1F-FB306073DFE3Q35224466-AC801DED-AAE5-4BD9-AF44-E785B249D64CQ35231277-7C8312D4-FB78-4C7E-8CB0-E8060392E4DFQ35257342-458B5766-0328-48DD-8CC9-5FE7EF8D9A31Q35277282-C4A3BB8E-EE82-47DE-951B-482FABE7C1C9Q35562475-1889F6B2-5882-4BC5-AA35-1AF923B8C369Q35596022-7CDC9917-E198-4CCA-9681-B0E135618603Q35880298-F463F82C-D31A-4A58-8F31-215C3AFA5AEBQ35893104-F3D80932-36C5-488B-83FE-7472D6F03383Q35893234-7C9C7F62-6C72-4944-AC61-4401CC3DA32CQ35897408-0BCF7FC9-BC11-4592-9CCE-38DC50CFA36BQ35922572-5740479A-0F56-444C-BD24-A5BCEC52CA8AQ36013661-59F833B6-A9F8-4671-AAB5-B9FAC3062260Q36077790-6BF90881-EFA5-474A-941A-65778CF4933FQ36250809-0A4E95A2-2F8F-40D5-B5AB-DB0DBA9820EBQ36329105-C10A2919-11D7-4141-AD46-4662E0A152EBQ36330853-41491DEF-4A2A-4129-BE77-2FCB289C558AQ36347623-C838398E-8216-41AD-8975-1AD8DCCBB478Q36447160-53E60D87-58CC-4942-A7CB-49A188ECF7CAQ36539394-1500E1C1-655A-4591-AD01-2F4FECFB18FF
P2860
Epidemiology of respiratory syncytial virus infection in Washington, D.C. II. Infection and disease with respect to age, immunologic status, race and sex.
description
1973 nî lūn-bûn
@nan
1973年の論文
@ja
1973年学术文章
@wuu
1973年学术文章
@zh
1973年学术文章
@zh-cn
1973年学术文章
@zh-hans
1973年学术文章
@zh-my
1973年学术文章
@zh-sg
1973年學術文章
@yue
1973年學術文章
@zh-hant
name
Epidemiology of respiratory sy ...... unologic status, race and sex.
@en
Epidemiology of respiratory sy ...... unologic status, race and sex.
@nl
type
label
Epidemiology of respiratory sy ...... unologic status, race and sex.
@en
Epidemiology of respiratory sy ...... unologic status, race and sex.
@nl
prefLabel
Epidemiology of respiratory sy ...... unologic status, race and sex.
@en
Epidemiology of respiratory sy ...... unologic status, race and sex.
@nl
P2093
P1476
Epidemiology of respiratory sy ...... unologic status, race and sex.
@en
P2093
Arrobio JO
Chanock RM
Parrott RH
P304
P356
10.1093/OXFORDJOURNALS.AJE.A121558
P407
P577
1973-10-01T00:00:00Z